| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |